Certificate under regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30 September, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Brawn Biotech Ltd has submitted a routine regulatory compliance certificate to BSE for the quarter ended 30 September 2025. The certificate was issued by RCMC Share Registry Pvt Ltd, the company's Registrar and Share Transfer Agent. It confirms that all share dematerialisation requests received from depository participants during the quarter were properly processed, with shares listed on the stock exchanges and the register of members updated with the depository's name as the registered owner within the required 15-day window. The filing was signed by Priyanka Sharma, Company Secretary & Compliance Officer, on 14 October 2025.
This is a purely procedural compliance filing required under SEBI rules and carries no material impact on the company's financials, operations, or stock price. It simply confirms that share demat activities were handled correctly during the quarter.